Gland Pharma Limited — Others, 11-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Gland Pharma has announced a board meeting to consider the financial results for the quarter and half-year. The company received a confirmation certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirming that all securities submitted for dematerialisation during the quarter were processed and listed appropriately. No requests for dematerialisation or rematerialisation were received in this period. This update ensures smooth securities handling and reflects ongoing compliance with shareholding records, supporting shareholder confidence.